Latest News and Press Releases
Want to stay updated on the latest news?
-
LOS ANGELES, CA, April 19, 2021 (GLOBE NEWSWIRE) -- Social Life Network, Inc. (OTC: WDLF), announces today that it has filed a $40,000,000 complaint against a convertible debt funder for multiple...
-
Press Release Nokia and Lenovo conclude patent cross-licensing agreement 7 April 2021 Espoo, Finland – Nokia and Lenovo conclude patent cross-licensing agreement. Nokia announced today that it...
-
Press Release Nokia and Samsung sign patent licensing agreement for video standards Agreement covers use of Nokia’s inventions in video standards 11 March 2021 Espoo, Finland –...
-
Hørsholm, Denmark (29 June 2020) – Oncology Venture A/S (“OV” or the “Company”) today announced that it has signed a definitive agreement out-licensing two clinical pipeline assets, LiPlaCis® and...
-
The licensing agreement of OT-101 to Autotelic BIO with the field of use limited to OT-101 (Trabedersen) with Interleukin-2 (OT-101/IL-2) combination became effective this week with the completion of...
-
AMES, Iowa, Dec. 23, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the company has entered into an exclusive worldwide license agreement with Ellipses...
-
ROCKVILLE, MD, and SHANGHAI, China, July 10, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative...
-
LOS ANGELES, Dec. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it entered into a license and supply agreement with Nestlé Health Science (NHSc), a global leader...
-
New York, New York, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Premiere Group, a wholly owned subsidiary of the Perfume Center of America Inc., has acquired the Derek Lam Beauty license, in a multi-year...
-
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing developmentExpand Zai Lab’s late-stage clinical pipeline with margetuximab and obtain rights to...